Pursuant to Regulation 30 of SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015, Dr Lal Pathlabs has informed about the details of proposed schedule of Analyst/institutional investor meetings.
The above information is a part of company’s filings submitted to BSE.